← brief for 2026-09-09 · Slowing decline

Structured medication review in elderly patients with chronic kidney disease to assess treatment appropriateness

Paper C Peer reviewed Observational

Key takeaways

Clinicians went through the full medicine list of older adults with chronic kidney disease to check whether each drug was still the right choice. Older kidney patients often take many drugs, and some need a lower dose or should be stopped once the kidneys weaken. Work like this shows a link between reviews and better prescribing, not proof that the reviews make people live longer. No abstract was posted, so the number of patients and the size of any effect are not available.

Who did this work

Gloria Navarro-Aznárez (Servicio Aragonés de Salud) · Herminia Navarro-Aznárez (Servicio Aragonés de Salud) · María Teresa García-Ruiz (Servicio Aragonés de Salud) · Laura Galino-Serrano (Servicio Aragonés de Salud) · Rosalía Díaz-Royo (Servicio Aragonés de Salud) · Alejandro Balongo-Gutiérrez (Servicio Aragonés de Salud) · Paula Berges-Mata (Servicio Aragonés de Salud) · Fátima Méndez-López (Universidad de Zaragoza) · María Antonia Sánchez-Calavera (Universidad de Zaragoza)

Source

Paper · OpenAlex, CKD works · 2026-09-08
https://doi.org/10.3389/fphar.2026.1915807